Welcome back to this weekly series on finding undervalued dividend growth stocks to research.
What can you say about the events that unfolded this week? The news coming out of Ukraine is both tragic and heroic. My heart goes out to the citizens of Ukraine and to the military that is defending their homeland. I can only hope that peace is restored and the violence is resolved. We should not be in a world where unprovoked military action is allowed to happen. I hope the global community stands up and pushes for resolution and order. It almost feels weird focusing on investing when people’s lives are being torn apart.
In this difficult time, the market was surprisingly positive. I think most of us were expecting significant losses this week but at the end the Dow was only down 0.74%, S&P 500 up 0.10%, and the NASDAQ down 0.16%. It just goes to show that there is no way to know what the market is going to do and no way for anyone to time the market. A steady hand and long term approach are our best resources. The markets as a whole are still down for the year so far.
With that said, my screening picked up some new names this week and here are some quality dividend growth stocks that are appearing undervalued based on all 5 of my valuation methods:
- Discount to Analyst Price Target
- 5% or more off the 52-week high
- Discounted Cash Flow (DCF)
- P/E Mean Reversion
- Dividend Yield Theory (DYT)
The new companies to make the list this week are:
BAC, BR, CMI, MSM, TSCO, UGI, and WBA
The remaining names – FNF, HBI, IIPR, LEG, MDT, MMM, SBUX, SWK, and TROW are a continuation of last week and remain undervalued.
This list should be used to begin your research to determine if the stock meets all of your investment goals and criteria. Valuation should only be one of many aspects you look at when deciding to make an investment.
Best of luck, happy investing, and check back next week for more undervalued stock ideas!
1 thought on “16 Undervalued Dividend Growth Stocks for the Week of 02/28/2022”